New anticancer agents in clinical development

ONCOLOGY

Volumn 9, Issue 11, 1995, Pages 1191-1199

  Eckardt, J ^a   Eckhardt, G ^a   Villalona Calero, M ^a   Drengler, R ^a   Von Hoff, D ^a  

^a CTRC Institute for Drug Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CYTARABINE; DOCETAXEL; FLUOROURACIL; GEMCITABINE; IRINOTECAN; NEW DRUG; PACLITAXEL; TOPOTECAN;

CANCER; CLINICAL TRIAL; DRUG DEVELOPMENT; DRUG STRUCTURE; HUMAN; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CLINICAL TRIALS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; FLUOROURACIL; HUMAN; PACLITAXEL; PRODRUGS; THYMIDYLATE SYNTHASE; TOPOTECAN;

EID: 0028807533     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)